rs1060499781
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025114.4(CEP290):c.6818_6818+1dupGG variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000274 in 1,460,904 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_025114.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460904Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726670
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 14 Pathogenic:1
- -
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis;C0687120:Nephronophthisis Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 402224). This variant has not been reported in the literature in individuals affected with CEP290-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a splice site in intron 49 of the CEP290 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). -
Senior-Loken syndrome 6;C1857780:Joubert syndrome 5;C1857821:Leber congenital amaurosis 10;C1970161:Meckel syndrome, type 4;C2673874:Bardet-Biedl syndrome 14 Pathogenic:1
- -
Joubert syndrome 5 Pathogenic:1
The c.6818+1_6818+2insGG splice variant in the CEP290 gene has not been previously reported in published literature and is absent from the population databases (ESP; 1000 Genomes; ExAC). Splice-site, nonsense, and frameshift variants have been described in the CEP290 gene in several affected individuals (including nonsense and frameshift variants downstream of this splice variant) and thus, loss of function is a known mechanism of disease. In silico splicing algorithms predict this variant will cause altered splicing (Human Splice Finder = Broken WT Donor Site, New Donor Site). Therefore, this collective evidence supports the classification of the c.6818+1_6818+2insGG as a Likely Pathogenic variant for Joubert Syndrome and Related Disorders. Because this gene is expressed in blood cells, RNA-splicing studies can be performed to validate this classification (see recommendation). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at